2,009
Views
13
CrossRef citations to date
0
Altmetric
Editorial

ADAR1: a promising new biomarker for esophageal squamous cell carcinoma?

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Han Xiao, Qian Cheng, Xinyu Wu, Yishu Tang, Jing Liu & Xin Li. (2019) ADAR1 may be involved in the proliferation of acute myeloid leukemia cells via regulation of the Wnt pathway. Cancer Management and Research 11, pages 8547-8555.
Read now

Articles from other publishers (12)

Shuai Xiao, Guo Huang, Weihong Zeng, Jun Zhou, Yukun Li, Tingyu Fan, Xiaomin Liu, Jiliang Xia & Xi Zeng. (2022) Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials. Clinical and Translational Oncology 25:3, pages 578-591.
Crossref
Zehua Zhang, Zhuyun Leng, Kang Fang, Mingchuang Sun, Zhaoxing Li, Le Kang, Tao Chen & Meidong Xu. (2022) Global research trend of esophageal squamous cell carcinoma from 2012 to 2022: a bibliometric analysis. Frontiers in Oncology 12.
Crossref
Tuba M. Ansary, MD Razib Hossain, Mayumi Komine & Mamitaro Ohtsuki. (2022) Immunotherapy for the Treatment of Squamous Cell Carcinoma: Potential Benefits and Challenges. International Journal of Molecular Sciences 23:15, pages 8530.
Crossref
Xing-xing Huo, Shu-jie Wang, Hang Song, Ming-de Li, Hua Yu, Meng Wang, Hong-xiao Gong, Xiao-ting Qiu, Yong-fu Zhu & Jian-ye Zhang. (2021) Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma. Frontiers in Pharmacology 12.
Crossref
Sho Takeda. (2021) The 2019 Incentive Award of the Okayama Medical Association in Cancer Research (2019 Hayashibara Prize and Yamada Prize)令和元年度岡山医学会賞 がん研究奨励賞(林原賞・山田賞). Okayama Igakkai Zasshi (Journal of Okayama Medical Association) 133:1, pages 1-3.
Crossref
Hong-Yue Ding, Wan-Yong Yang, Li-Hong Zhang, Li Li, Feng Xie, Hua-Yi Li, Xiao-Yu Chen, Zeng Tu, Yi Li, Yong Chen & Sheng-Yong Yang. (2020) 8-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway. Cell Transplantation 29, pages 096368972095865.
Crossref
Wei Wang, Ying Xie, Fei Chen, Xu Liu, Li-Li Zhong, Hai-Qiang Wang & Qing-Chang Li. (2019) LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World Journal of Gastroenterology 25:29, pages 3972-3984.
Crossref
Wei Wang, Ying Xie, Fei Chen, Xu Liu, Li-Li Zhong, Hai-Qiang Wang & Qing-Chang Li. (2019) LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer. World Journal of Gastroenterology 25:29, pages 0-0.
Crossref
Ji-Feng Feng, Sheng Chen & Xun Yang. (2017) Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus. Oncotarget 8:38, pages 63132-63139.
Crossref
Tatiana Altadill, Tyrone M. Dowdy, Kirandeep Gill, Armando Reques, Smrithi S. Menon, Cristian P. Moiola, Carlos Lopez-Gil, Eva Coll, Xavier Matias-Guiu, Silvia Cabrera, Angel Garcia, Jaume Reventos, Stephen W. Byers, Antonio Gil-Moreno, Amrita K. Cheema & Eva Colas. (2017) Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis. Scientific Reports 7:1.
Crossref
Hebing Zhou, Jinqing Li, Yuan Jian, Tingting Chen, Haiteng Deng, Juan Zhang, Hui Zeng, Zhijuan Shan & Wenming Chen. (2016) Effects and mechanism of arsenic trioxide in combination with rmhTRAIL in multiple myeloma. Experimental Hematology 44:2, pages 125-131.e11.
Crossref
Yingcai Hong, Wen Chen, Xiaojun Du, Huiwen Ning, Huaisheng Chen, Ruiqing Shi, Shaolin Lin, Rongyu Xu, Jinrong Zhu, Shu Wu & Haiyu Zhou. (2015) Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma. Oncotarget 6:31, pages 31241-31254.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.